Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypofractionated Dose”

107 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 107 results

Early research (Phase 1)Ended earlyNCT02252796
What this trial is testing

Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
West Virginia University 1
Testing effectiveness (Phase 2)Study completedNCT00126165
What this trial is testing

Short-course Hypofractionated Radiotherapy for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Alberta Health services 72
Not applicableActive Not RecruitingNCT03239626
What this trial is testing

Postoperative Hypofractionated Intensity-modulated Radiation Therapy in Cervical Cancer

Who this might be right for
Cervix CancerRadiotherapy, AdjuvantRadiotherapy, Intensity-Modulated+1 more
Samsung Medical Center 120
Large-scale testing (Phase 3)Not Yet RecruitingNCT06855589
What this trial is testing

Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer Patients: 6 Versus 12 Months.

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Charles LeMoyne Hospital 400
Large-scale testing (Phase 3)Study completedNCT02688036
What this trial is testing

Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC

Who this might be right for
Carcinoma, Small CellLung Neoplasms
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 860
Testing effectiveness (Phase 2)UnknownNCT05588206
What this trial is testing

Dose-escalation by Hypofractionated Stereotactic Radiotherapy for Brain Metastases in Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung CancerStage IV Non-small Cell Lung CancerBrain Metastases
First People's Hospital of Hangzhou 21
Testing effectiveness (Phase 2)UnknownNCT03989596
What this trial is testing

Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue Sarcomas

Who this might be right for
SarcomaAlveolar Soft Part SarcomaClear Cell Sarcoma+8 more
Maria Sklodowska-Curie National Research Institute of Oncology 30
Testing effectiveness (Phase 2)Looking for participantsNCT06024824
What this trial is testing

Dose-Painted Intensity Modulated Radiotherapy Pancreas (DP-IMRT Pancreas)

Who this might be right for
Pancreatic Adenocarcinoma
Cancer Trials Ireland 49
Not applicableNot Yet RecruitingNCT07831889
What this trial is testing

Hypofractionated Radiotherapy After Breast Reconstruction for Breast Cancer

Who this might be right for
Breast Cancer
Tianjin Medical University Cancer Institute and Hospital 960
Not applicableStudy completedNCT03239613
What this trial is testing

Postoperative Hypofractionated Intensity-modulated Radiation Therapy with Concurrent Chemotherapy in Cervical Cancer

Who this might be right for
Cervix CancerRadiotherapy, AdjuvantRadiotherapy, Intensity-Modulated+2 more
Samsung Medical Center 84
Not applicableLooking for participantsNCT06817668
What this trial is testing

Evaluating Tolerability of ePUHRT With Brachytherapy Boost

Who this might be right for
Prostate Cancer
Indiana University 31
Testing effectiveness (Phase 2)UnknownNCT00126802
What this trial is testing

The Role of Tomotherapy in Hypofractionated/Dose Escalated Conformal Radiation Treatment for High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
AHS Cancer Control Alberta 60
Testing effectiveness (Phase 2)UnknownNCT01505075
What this trial is testing

Safety and Efficacy Study of Hypofractionated Radiotherapy and Androgen Deprivation Therapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Sunnybrook Health Sciences Centre 30
Large-scale testing (Phase 3)UnknownNCT00667888
What this trial is testing

A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 225
Early research (Phase 1)Active Not RecruitingNCT04147806
What this trial is testing

A Pilot Study of Ultra-High-Dose Hypofractionated or Single-Dose Radiotherapy for Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Albert Einstein College of Medicine 31
Large-scale testing (Phase 3)Study completedNCT02163226
What this trial is testing

Trial Evaluating Rapid Delivery of Dose Escalated Hypofractionated Radiotherapy for Patients Diagnosed With Bone Metastases for Effective Palliation of Symptoms

Who this might be right for
Bone Metastases
M.D. Anderson Cancer Center 167
Testing effectiveness (Phase 2)Looking for participantsNCT06386315
What this trial is testing

Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma

Who this might be right for
Indolent B-Cell Non-Hodgkin LymphomaRecurrent Indolent B-Cell Non-Hodgkin LymphomaRefractory Indolent B-Cell Non-Hodgkin Lymphoma+2 more
Mayo Clinic 112
Not applicableUnknownNCT02895854
What this trial is testing

LDR Brachytherapy Versus SBRT for Low and Intermediate Risk Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Kuopio University Hospital 44
Testing effectiveness (Phase 2)UnknownNCT01849510
What this trial is testing

Efficacy of Dose Intensified Radiotherapy of Spinal Metastases by Hypofractionated Radiation and IGRT hfSRT Mediated Boost

Who this might be right for
Spinal Metastases
University of Erlangen-Nürnberg Medical School 155
Early research (Phase 1)Study completedNCT02172846
What this trial is testing

Hypofractionated Proton Beam Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Stage II-III Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Washington University School of Medicine 23
Next Page